DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy

PEGylated liposomes have transformed chemotherapeutic use of doxorubicin by reducing its cardiotoxicity; however, it remains unclear whether liposomal doxorubicin is therapeutically superior to free doxorubicin. Here, we demonstrate a novel PEGylated liposome system, named DAFODIL (Doxorubicin And 5...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Control Release
Main Authors: Camacho, Kathryn M., Menegatti, Stefano, Vogus, Douglas R., Pusuluri, Anusha, Fuchs, Zoë, Jarvis, Maria, Zakrewsky, Michael, Evans, Michael A., Chen, Renwei, Mitragotri, Samir
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5289372/
https://ncbi.nlm.nih.gov/pubmed/27034194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2016.03.027
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados